Giselle Berenice Vela Sancho

Mrs. Giselle Berenice Vela Sancho

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2026 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
PDF file
FAFrancisco Javier Alcaraz-Baturoni
Francisco Javier Alcaraz-Baturoni
JIJessica Paola Ibarra-González
Jessica Paola Ibarra-González
Mario Alberto Alarcón SánchezMario Alberto Alarcón Sánchez
Mario Alberto Alarcón Sánchez
GSGiselle Berenice Vela Sancho
Giselle Berenice Vela Sancho
JFJavier Flores-Fraile
Javier Flores-Fraile
Sarah Monserrat LomeliSarah Monserrat Lomeli
Sarah Monserrat Lomeli
Pyogenic granuloma (PG) is a common reactive vascular hyperplasia of the oral cavity with multifactorial origin. Although benign, it shows clinical variability and may recur if predisposing factors persist. This report describes two oral PG cases with different etiologies. A 68-year-old man presented with a mucogingival lesion associated with dental calculus, while a 29-year-old woman developed a lesion during pregnancy that continued after delivery. Both were treated with complete surgical excision and elimination of local irritants. Histopathology confirmed PG, characterized by granulation tissue rich in vascular spaces, inflammatory infiltrate, and areas of epithelial ulceration. Follow-up visits showed good healing and no recurrence. These cases emphasize the interaction of local agents like calculus and biofilm with systemic factors such as gestational hormonal changes. PG management requires identifying contributing factors and performing thorough surgical removal, though alternative methods—cryosurgery, electrosurgery, or laser—may be useful in selected scenarios.

Verified
Journal Article
Open access
PDF file
GSGiselle Berenice Vela Sancho
Giselle Berenice Vela Sancho
RBRicardo E. Buendia-Corona
Ricardo E. Buendia-Corona
MRMaría Paulina Reyes
María Paulina Reyes
MMMario Alberto Mireles-Ramírez
Mario Alberto Mireles-Ramírez
Christian Griñán-FerréChristian Griñán-Ferré
Christian Griñán-Ferré
Daniel Ortuño-SahagúnDaniel Ortuño-Sahagún
Daniel Ortuño-Sahagún
Multiple sclerosis (MS), the most prevalent chronic inflammatory, demyelinating and neurodegenerative disease of the central nervous system in young adults, exhibits marked sexual dimorphism, with a 3:1 female-to-male ratio, but more severe symptoms and greater neurological damage in males. Increasing attention has focused on identifying circulating molecules that reflect inflammatory activity within the central nervous system and could clarify the mechanisms underlying MS. Pleiotrophin (PTN), a cytokine implicated in autoimmune and neurological diseases, is significantly elevated in patients with relapsing-remitting MS (RRMS). To explore the potential contribution of PTN and its receptors to neuroinflammatory signaling, we quantified the mRNA expression of PTN receptors in peripheral blood mononuclear cells from RRMS patients compared to untreated RRMS patients and healthy control subjects. We further performed an in silico molecular docking and molecular dynamics analysis to assess the possible functional significance of PTN-receptor interactions. Our results show a significant overexpression of integrin subunit beta-3 (ITGB3) mRNA in peripheral blood mononuclear cells from RRMS patients compared to healthy control subjects. Molecular docking shows that PTN could binds to the metal ion-dependent adhesion site domain of ITGB3 via Mg2+/Ca2+-mediated stabilization and has a higher binding affinity than fibrinogen, the canonical endogenous ligand. These findings suggest that ITGB3 could be a dynamically regulated integrin receptor in RRMS that may participate in PTN-driven neuroinflammatory pathways in peripheral blood immune cells, influenced by disease stage, sex, and immunotherapy. While our results support the biological plausibility of PTN–ITGB3 engagement, they remain hypothesis-generating and require functional validation. The integration of molecular expression data and computational modeling underscores the potential involvement of ITGB3 as a possible participant in MS and warrants further investigation of its clinical and mechanistic role.

9 September 2025 in MRS Communications
Verified
Journal Article
Closed access
PDF file
ZSZ. Gómez Soto
Z. Gómez Soto
GSGiselle Berenice Vela Sancho
Giselle Berenice Vela Sancho
MVMaría Aurora Veloz-Rodríguez
María Aurora Veloz-Rodríguez
OAOtilio A. Acevedo-Sandoval
Otilio A. Acevedo-Sandoval
Eduardo Cornejo VelazquezEduardo Cornejo Velazquez
Eduardo Cornejo Velazquez
RGRosa Angeles Vázquez García
Rosa Angeles Vázquez García